| 1 | 
                
                    S1PR1
                
             💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Fingolimod 
                
                    Fingolimod
                
             💬
 | 
                
                    Fingolimod
                
             | [3]  13 13, 14, 156 💬
 | 
| 2 | 
                
                    FCGRT
                
             💬
 | - | Nipocalimab 
                
                    Nipocalimab
                
             💬
 | 
                
                    Nipocalimab
                
             | [6]  11 11, 14, 46, 49, 53, 61 💬
 | 
| 3 | 
                
                    FCGRT
                
             💬
 | - | Efgartigimod alfa 
                
                    Efgartigimod alfa
                
             💬
 | 
                
                    Efgartigimod alfa
                
             | [6]  11 11, 14, 35, 53, 63, 162 💬
 | 
| 4 | 
                
                    FCGRT
                
             💬
 | - | Batoclimab 
                
                    Batoclimab
                
             💬
 | 
                
                    Batoclimab
                
             | [2]  11 11, 14 💬
 | 
| 5 | 
                
                    FCGRT
                
             💬
 | - | Rozanolixizumab 
                
                    Rozanolixizumab
                
             💬
 | 
                
                    Rozanolixizumab
                
             | [3]  11 11, 14, 63 💬
 | 
| 6 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone 
                
                    Dexamethasone
                
             💬
 | 
                
                    Dexamethasone
                
             | [22]  13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
 | 
| 7 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone 
                
                    Methylprednisolone
                
             💬
 | 
                
                    Methylprednisolone
                
             | [46]  2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
 | 
| 8 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone 
                
                    Prednisolone
                
             💬
 | 
                
                    Prednisolone
                
             | [42]  3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
 | 
| 9 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone 
                
                    Prednisone
                
             💬
 | 
                
                    Prednisone
                
             | [45]  2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
 | 
| 10 | 
                
                    HRH1
                
             💬
 | [3]  Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Chlorphenamine 
                
                    Chlorphenamine
                
             💬
 | 
                
                    Chlorpheniramine
                
             | [1]  14 14 💬
 | 
| 11 | 
                
                    KCNA4
                
             💬
 | [2]  Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | Dalfampridine 
                
                    Dalfampridine
                
             💬
 | 
                
                    Dalfampridine
                
             | [5]  3 3, 4, 6, 13, 14 💬
 | 
| 12 | 
                
                    KCNC3
                
             💬
 | [1]  Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine 
                
                    Dalfampridine
                
             💬
 | 
                
                    Dalfampridine
                
             | [5]  3 3, 4, 6, 13, 14 💬
 | 
| 13 | 
                
                    KCND2
                
             💬
 | [1]  Serotonergic synapse Serotonergic synapse | Dalfampridine 
                
                    Dalfampridine
                
             💬
 | 
                
                    Dalfampridine
                
             | [5]  3 3, 4, 6, 13, 14 💬
 | 
| 14 | 
                
                    KCND3
                
             💬
 | [1]  Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine 
                
                    Dalfampridine
                
             💬
 | 
                
                    Dalfampridine
                
             | [5]  3 3, 4, 6, 13, 14 💬
 | 
| 15 | 
                
                    MC2R
                
             💬
 | [5]  cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome | Corticotropin 
                
                    Corticotropin
                
             💬
 | 
                
                    Corticotropin
                
             | [12]  2 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222 💬
 | 
| 16 | 
                
                    TOP2A
                
             💬
 | [1]  Platinum drug resistance Platinum drug resistance | Etoposide 
                
                    Etoposide
                
             💬
 | 
                
                    Etoposide
                
             | [11]  11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
 | 
| 17 | 
                
                    TOP2B
                
             💬
 | [1]  Platinum drug resistance Platinum drug resistance | Etoposide 
                
                    Etoposide
                
             💬
 | 
                
                    Etoposide
                
             | [11]  11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
 | 
| 18 | 
                
                    C5
                
             💬
 | [11]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Eculizumab 
                
                    Eculizumab
                
             💬
 | 
                
                    Eculizumab
                
             | [7]  11 11, 13, 14, 61, 62, 109, 222 💬
 | 
| 19 | 
                
                    MS4A1
                
             💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab 
                
                    Rituximab
                
             💬
 | 
                
                    Rituximab
                
             | [48]  11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
 |